The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


SKP SKYEPHARMA PLC ORD 100P

SKYEPHARMA  Currency  GBX  Premium Equity Commercial Companies


Income Statement  (£ m) 31-Dec-14 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10
Continuing Operations
Revenue  73.80 62.60 49.90 55.20 58.10
Operating Profit/(Loss)  21.60 13.60 17.10 9.80 14.50
Net Interest  7.00 14.10 11.80 0.40 12.30
Profit Before Tax  -9.90 -1.00 -10.40 -1.00 6.50
Profit After Tax  -10.50 0.80 -10.60 -1.60 6.30
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  -10.50 0.80 -10.60 -1.60 6.30
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  -10.50 0.80 -10.60 -1.60 6.30
 
Continuing EPS
Earnings per Share - Basic  -12.30p 1.80p -36.00p -6.70p 26.30p
Earnings per Share - Diluted  -12.30p 1.70p -36.00p -6.70p 15.30p
Earnings per Share - Adjusted  18.80p 1.80p 1.10p 1.90p 29.60p
Continuing and Discontinued EPS
Earnings per Share - Basic  -12.30p 1.80p -14.90p -6.70p 26.30p
Earnings per Share - Diluted  -12.30p 1.70p -14.90p -6.70p 15.30p
Earnings per Share - Adjusted  18.80p 1.80p 22.20p 1.90p 29.60p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 31-Dec-14 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10
Assets
Non-Current Assets
Property, Plant & Equipment  21.60 28.50 31.90 29.80 29.50
Intangible Assets  6.10 5.30 5.10 5.80 8.40
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  3.90 0.00 0.00 4.20 0.10
  31.60 33.80 37.00 39.80 38.00
Current Assets
Inventories  10.40 8.80 5.80 0.80 1.30
Trade & Other Receivables  16.60 15.50 13.30 10.50 11.50
Cash at Bank & in Hand  32.40 16.50 16.40 15.20 29.00
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 0.00 4.20
  59.40 40.80 35.50 26.50 46.00
 
Total Assets  91.00 74.60 72.50 66.30 84.00
 
Liabilities
Current Liabilities
Borrowings  -5.60 -9.80 -10.10 -19.60 -27.30
Other Current Liabilities  -33.40 -23.70 -24.20 -14.80 -17.70
  -39.00 -33.50 -34.30 -34.40 -45.00
 
Net Current Assets  20.40 7.30 1.20 -7.90 1.00
 
Non-Current Liabilities
Borrowings  -11.80 -90.90 -87.00 -94.60 -100.00
Provisions  -0.20 -0.10 -5.30 -5.10 0.00
Other Non-Current Liabilities  -12.80 -14.70 -11.90 -13.90 -18.90
  -24.80 -105.70 -104.20 -113.60 -118.90
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -63.80 -139.20 -138.50 -148.00 -163.90
 
Net Assets  27.20 -64.60 -66.00 -81.70 -79.90
 
Capital & Reserves
Share Capital  179.40 120.70 120.70 98.50 98.50
Share Premium Account  407.20 361.70 361.70 390.20 390.20
Other Reserves  -16.60 -16.20 -16.40 -16.80 -16.40
Retained Earnings  -542.80 -530.80 -532.00 -553.60 -552.20
Shareholders Funds  27.20 -64.60 -66.00 -81.70 -79.90
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  27.20 -64.60 -66.00 -81.70 -79.90

Ratios - based on IFRS 31-Dec-14 31-Dec-13 31-Dec-12 31-Dec-11 31-Dec-10
Continuing Operations
PE Ratio - Adjusted  17.82 62.64 65.00 18.82 1.06
PEG - Adjusted  0.02 0.98 -1.54 -0.20 0.00
Earnings per Share Growth - Adjusted  944.44% 63.64% -42.11% -93.58% 2959900.00%
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  86.52p 135.79p 169.15p 230.00p 242.08p
Pre-Tax Profit per Share  -11.61p -2.17p -35.25p -4.17p 27.08p
Operating Margin  -4.07% 20.77% 2.40% -1.45% 31.33%
Return on Capital Employed  -6.50% 37.43% 4.47% -1.89% 42.63%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  20.13p -151.53p -154.14p -365.45p -368.79p
Net Gearing  -55.15% -130.34% -122.27% -121.18% -123.03%

Data is provided by Morningstar


SKYEPHARMA share - fundamentals

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds